Apogee Therapeutics
APGE
APGE
205 hedge funds and large institutions have $5.27B invested in Apogee Therapeutics in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
85% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 46
18% more funds holding
Funds holding: 174 → 205 (+31)
27.12% less ownership
Funds ownership: 129.22% → 102.1% (-27%)
Holders
205
Holding in Top 10
9
Calls
$27.8M
Puts
$14.4M
Top Buyers
| 1 | +$172M | |
| 2 | +$99.3M | |
| 3 | +$82.4M | |
| 4 |
BlackRock
New York
|
+$69.2M |
| 5 |
PA
Perceptive Advisors
New York
|
+$61.6M |
Top Sellers
| 1 | -$54.4M | |
| 2 | -$32.1M | |
| 3 | -$25.3M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$25.1M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$22.6M |
